89 related articles for article (PubMed ID: 20685810)
1. Role of reduced expression of SMAD4 in papillary thyroid carcinoma.
D'Inzeo S; Nicolussi A; Ricci A; Mancini P; Porcellini A; Nardi F; Coppa A
J Mol Endocrinol; 2010 Oct; 45(4):229-44. PubMed ID: 20685810
[TBL] [Abstract][Full Text] [Related]
2. A novel human Smad4 mutation is involved in papillary thyroid carcinoma progression.
D'Inzeo S; Nicolussi A; Donini CF; Zani M; Mancini P; Nardi F; Coppa A
Endocr Relat Cancer; 2012 Feb; 19(1):39-55. PubMed ID: 22109972
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
4. Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines.
Cerutti JM; Ebina KN; Matsuo SE; Martins L; Maciel RM; Kimura ET
J Endocrinol Invest; 2003 Jun; 26(6):516-21. PubMed ID: 12952364
[TBL] [Abstract][Full Text] [Related]
5. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Smad4 C324Y mutation on thyroid cell proliferation.
D'Inzeo S; Nicolussi A; Nardi F; Coppa A
Int J Oncol; 2013 Jun; 42(6):1890-6. PubMed ID: 23591524
[TBL] [Abstract][Full Text] [Related]
8. Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer.
Garcia-Rendueles AR; Rodrigues JS; Garcia-Rendueles ME; Suarez-Fariña M; Perez-Romero S; Barreiro F; Bernabeu I; Rodriguez-Garcia J; Fugazzola L; Sakai T; Liu F; Cameselle-Teijeiro J; Bravo SB; Alvarez CV
Oncogene; 2017 Feb; 36(5):652-666. PubMed ID: 27452523
[TBL] [Abstract][Full Text] [Related]
9. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
[TBL] [Abstract][Full Text] [Related]
11. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
12. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits metastasis in human papillary thyroid carcinoma BCPAP cells via down-regulation of the TGF-β/Smad2/3 signaling pathway.
Zhang L; Cheng X; Gao Y; Zhang C; Bao J; Guan H; Yu H; Lu R; Xu Q; Sun Y
Exp Cell Res; 2016 Feb; 341(2):157-65. PubMed ID: 26826337
[TBL] [Abstract][Full Text] [Related]
14. GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.
Dong XM; Yin RH; Yang Y; Feng ZW; Ning HM; Dong L; Zheng WW; Tang LJ; Wang J; Jia YX; Jiang YN; Liu ED; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Yang XM
Cell Signal; 2014 May; 26(5):1089-97. PubMed ID: 24509415
[TBL] [Abstract][Full Text] [Related]
15. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
de Kroon LM; Narcisi R; van den Akker GG; Vitters EL; Blaney Davidson EN; van Osch GJ; van der Kraan PM
Sci Rep; 2017 Feb; 7():43164. PubMed ID: 28240243
[TBL] [Abstract][Full Text] [Related]
16. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
[TBL] [Abstract][Full Text] [Related]
17. ChIP-seq defined genome-wide map of TGFβ/SMAD4 targets: implications with clinical outcome of ovarian cancer.
Kennedy BA; Deatherage DE; Gu F; Tang B; Chan MW; Nephew KP; Huang TH; Jin VX
PLoS One; 2011; 6(7):e22606. PubMed ID: 21799915
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
19. An inhibitory role of NEK6 in TGFβ/Smad signaling pathway.
Zuo J; Ma H; Cai H; Wu Y; Jiang W; Yu L
BMB Rep; 2015 Aug; 48(8):473-8. PubMed ID: 25523445
[TBL] [Abstract][Full Text] [Related]
20. STC1 regulates glioblastoma migration and invasion via the TGF‑β/SMAD4 signaling pathway.
Xiong Y; Wang Q
Mol Med Rep; 2019 Oct; 20(4):3055-3064. PubMed ID: 31432189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
